Clinical Trial Update: Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study evaluating escalating doses of an investigational iron chelator in patients with Transfusional Iron Overload and Beta-t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Transfusional Iron Overload

Drugs mentioned

• Iron chelator (investigational)

Snippet

Sponsor: FerroKin BioSciences, Inc. | Conditions: Transfusional Iron Overload, Beta-thalassemia | Phase 1 | Status: COMPLETED